Summary

US Cardiac Arrhythmia Monitoring Devices Market is valued approximately USD 2.32 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.34% over the forecast period 2024-2032. Cardiac arrhythmia monitoring devices are tools that track the heart's electrical activity to detect irregular rhythms. They include portable devices like Holter monitors for continuous recording over a day or two, event monitors for short-term tracking of symptoms, implantable loop recorders for long-term monitoring under the skin, and mobile cardiac telemetry for real-time data transmission. These devices are crucial in diagnosing and managing arrhythmias by providing valuable information for treatment decisions. The surge in adoption of implantable devices is a key trend that is supporting to the growth of the US Cardiac Arrhythmia Monitoring Devices Market. Implantable cardiac monitors, such as implantable loop recorders (ILRs) and insertable cardiac monitors (ICMs), are becoming more prevalent. These devices offer long-term monitoring of patients with intermittent or hard-to-detect arrhythmias, providing valuable data for diagnosis and treatment planning.

In the United States, the cardiac arrhythmia monitoring devices market is projected to experience significant growth owing to the widespread adoption of advanced cardiovascular solutions and the presence of sophisticated healthcare infrastructure. The Centers for Disease Control and Prevention (CDC) forecasts that by 2030, approximately 12.1 million individuals in the US will be diagnosed with atrial fibrillation (AFib), the most prevalent type of cardiac arrhythmia. This increasing prevalence underscores the rising demand for cardiac arrhythmia monitoring devices, thus fueling market expansion. Additionally, Mobile Cardiac Outpatient Telemetry (MCOT) is gaining traction in the US. For instance, in January 2022, Biotricity received 510(k) clearance from the FDA for its Biotres Cardiac Monitoring Device, designed for ECG and arrhythmia monitoring. This wearable Holter patch device enables continuous three-channel recording of ECG data, contributing to the company's growth in the wireless devices market segment within the US. These developments are presenting various growth prospects for the US Cardiac Arrhythmia Monitoring Devices Market over the anticipated years. However, high cost of remote cardiac arrhythmia monitoring and competition from alternative methods is expected to stifle market growth during the forecast period 2024-2032.
Major market player included in this report are:
ACSDiagnostics, Inc.
AliveCor Inc.
Abbott Laboratories
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10



The detailed segments and sub-segment of the market are explained below:

By Devices
Event Monitoring Devices
Continuous Rhythm Monitoring Devices
Holter Monitoring Devices
Other Devices

By Service Providers
Mobile Cardiac Telemetry Monitoring Service Providers
Independent Diagnostic Testing Facilities/Clinics

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. US Cardiac Arrhythmia Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Cardiac Arrhythmia Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Devices
2.2.2. By Service Providers
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Cardiac Arrhythmia Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Cardiac Arrhythmia Monitoring Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Cardiac Arrhythmia Monitoring Devices Market Size & Forecasts by Devices 2022-2032
5.1. Event Monitoring Devices
5.2. Continuous Rhythm Monitoring Devices
5.3. Holter Monitoring Devices
5.4. Other Devices
Chapter 6. US Cardiac Arrhythmia Monitoring Devices Market Size & Forecasts by Service Providers 2022-2032
6.1. Mobile Cardiac Telemetry Monitoring Service Providers
6.2. Independent Diagnostic Testing Facilities/Clinics
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. ACSDiagnostics, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. AliveCor Inc.
7.3.3. Abbott Laboratories
7.3.4. Company 4
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes